Harnessing Oncolytic Virus-mediated Antitumor Immunity

Harnessing Oncolytic Virus-mediated Antitumor Immunity

Bibliographic Details
Main Author:	Volker eSchirrmacher
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2014-11-01
Series:	Frontiers in Oncology
Subjects:	Oncolytic Virotherapy oncolytic virus anti-tumor activity Anti-Viral Response tumor-associated antigen immunotherapeutic approaches
Online Access:	http://journal.frontiersin.org/Journal/10.3389/fonc.2014.00337/full

Similar Items

Harnessing oncolytic virus-mediated immunity
Published: (2015)

Oncolytic virus delivery: from nano-pharmacodynamics to enhanced oncolytic effect
by: Yokoda R, et al.
Published: (2017-11-01)

Exploiting tumor epigenetics to improve oncolytic virotherapy
by: Nicole E. Forbes, et al.
Published: (2013-09-01)

Simultaneous Tumor and Stroma Targeting by Oncolytic Viruses
by: Anne Everts, et al.
Published: (2020-11-01)

Targeting tumor vasculature through oncolytic virotherapy: recent advances
by: Toro Bejarano M, et al.
Published: (2015-11-01)

Perspectives on immunotherapy via oncolytic viruses
by: Alberto Reale, et al.
Published: (2019-02-01)

Bovine pestivirus is a new alternative virus for multiple myeloma oncolytic virotherapy
by: Valentina Marchica, et al.
Published: (2020-07-01)

Oncolytic Virotherapy with Myxoma Virus
by: Masmudur M. Rahman, et al.
Published: (2020-01-01)

Pharmacological modulation of anti-tumor immunity induced by oncolytic viruses
by: Nicole E. Forbes, et al.
Published: (2014-07-01)

Prospects for Using Expression Patterns of Paramyxovirus Receptors as Biomarkers for Oncolytic Virotherapy
by: Olga V. Matveeva, et al.
Published: (2020-12-01)

Measles to the Rescue: A Review of Oncolytic Measles Virus
by: Sarah Aref, et al.
Published: (2016-10-01)

Oncolytic viruses as anticancer vaccines
by: Norman eWoller, et al.
Published: (2014-07-01)

Editorial announcing PubMed indexing of Oncolytic Virotherapy
by: Farassati F
Published: (2017-02-01)

From Benchtop to Bedside: A Review of Oncolytic Virotherapy
by: Audrey H. Choi, et al.
Published: (2016-08-01)

Oncolytic virus immunotherapy: future prospects for oncology
by: Junaid Raja, et al.
Published: (2018-12-01)

Decreasing the Susceptibility of Malignant Cells to Infection Does Not Impact the Overall Efficacy of Myxoma Virus-Based Oncolytic Virotherapy
by: Erica B. Flores, et al.
Published: (2020-12-01)

Advances in the design and development of oncolytic measles viruses
by: Hutzen B, et al.
Published: (2015-08-01)

Cytotoxic effect of dual fluorescent-labeled oncolytic herpes simplex virus type 1 on mouse tumorigenic cell lines
by: Shahriyar Abdoli, et al.
Published: (2019-01-01)

Monitoring the Efficacy of Oncolytic Viruses via Gene Expression
by: Ashley Ansel, et al.
Published: (2017-11-01)

Delivery and Biosafety of Oncolytic Virotherapy
by: Lizhi Li, et al.
Published: (2020-04-01)

Oncolytic Adenovirus Coding for a Variant Interleukin 2 (vIL-2) Cytokine Re-Programs the Tumor Microenvironment and Confers Enhanced Tumor Control
by: Dafne C. A. Quixabeira, et al.
Published: (2021-05-01)

Dendritic Cells in Oncolytic Virus-Based Anti-Cancer Therapy
by: Youra Kim, et al.
Published: (2015-12-01)

Oncolytic Virotherapy in Glioma Tumors
by: Sergio Rius-Rocabert, et al.
Published: (2020-10-01)

Emerging role of Natural killer cells in oncolytic virotherapy
by: Bhat R, et al.
Published: (2015-03-01)

Oncolytic viruses as a promising therapeutic strategy for hematological malignancies
by: Chen Yang, et al.
Published: (2021-07-01)

Oncolytic viruses sensitize human tumor cells for NY-ESO-1 tumor antigen recognition by CD4+ effector T cells.
by: Tiphaine Delaunay, et al.
Published: (2018-03-01)

Extended disease-free interval of 6 years in a recurrent glioblastoma multiforme patient treated with G207 oncolytic viral therapy
by: Whisenhunt Jr TR, et al.
Published: (2015-01-01)

Overcoming Tumor Resistance to Oncolyticvaccinia Virus with Anti-PD-1-Based Combination Therapy by Inducing Antitumor Immunity in the Tumor Microenvironment
by: So Young Yoo, et al.
Published: (2020-06-01)

Oncolytic viruses for the treatment of malignant glioma
by: Hong⁃yu LIU, et al.
Published: (2020-02-01)

Efficient Delivery and Replication of Oncolytic Virus for Successful Treatment of Head and Neck Cancer
by: Masakazu Hamada, et al.
Published: (2020-09-01)

Oncolytic Adenoviruses in Cancer Treatment
by: Ramon Alemany
Published: (2014-02-01)

Oncolytic Sendai Virus Therapy of Canine Mast Cell Tumors (A Pilot Study)
by: Galina V. Ilyinskaya, et al.
Published: (2018-06-01)

To Infection and Beyond: The Multi-Pronged Anti-Cancer Mechanisms of Oncolytic Viruses
by: Kevin A. Cassady, et al.
Published: (2016-02-01)

Exploring Reovirus Plasticity for Improving Its Use as Oncolytic Virus
by: Vera Kemp, et al.
Published: (2015-12-01)

Promising oncolytic agents for metastatic breast cancer treatment
by: Cody JJ, et al.
Published: (2015-06-01)

Immunotherapeutic Potential of Oncolytic H-1 Parvovirus: Hints of Glioblastoma Microenvironment Conversion towards Immunogenicity
by: Assia L. Angelova, et al.
Published: (2017-12-01)

Recombinant Immunomodulating Lentogenic or Mesogenic Oncolytic Newcastle Disease Virus for Treatment of Pancreatic Adenocarcinoma
by: Pascal Buijs, et al.
Published: (2015-06-01)

Oncolytic virotherapy for head and neck cancer: current research and future developments
by: Malhotra A, et al.
Published: (2015-07-01)

Potential of oncolytic viruses in the treatment of multiple myeloma
by: Bartee E
Published: (2018-02-01)

Modulation of the Intratumoral Immune Landscape by Oncolytic Herpes Simplex Virus Virotherapy
by: Jie Yin, et al.
Published: (2017-06-01)